Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADVFN PLC Director's Dealing 2019

Jan 16, 2019

7468_dirs_2019-01-16_18c21b46-c1dd-4c9d-9255-dc94c1736f74.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2954N

ADVFN PLC

16 January 2019

For immediate release

16 January 2019

ADVFN PLC

("ADVFN" or the "Company")

Exercise and award of Options, TVR and Director / PDMR Shareholding

ADVFN announces that Mr Clem Chambers, CEO, on 15 January 2019 exercised existing options over a total of 40,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares") at a price of £0.3125 per Ordinary Share.

Accordingly, an application will be made for the new Ordinary Shares to be admitted to trading on AIM ("Admission"). The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue and it is expected that Admission will become effective and dealings will commence on or around 23 January 2019.

Following Admission, the Company will have 25,663,846 Ordinary Shares in issue and admitted to trading on AIM and Mr Chambers will be interested in 563,198 Ordinary Shares representing 2.19% of the Company's enlarged issued share capital.  

The Board on 15 January 2019 awarded an option to Clem Chambers to subscribe for, in aggregate, 80,000 new Ordinary Shares pursuant to the Company's Share Option Plan 2014 ("Option Plan"). Under the Option Plan, the exercise price of the options is equal to the closing mid-market price of an Ordinary Share for the last dealing day immediately preceding the date on which the option is to be granted, in this instance being 27.5p on Monday, 14 January 2019. The new options (representing 0.3 per cent. of the current issued share capital of the Company) vest on 24 January 2019 and lapse unless otherwise exercised on 12 December 2024.

More information on ADVFN can be found at: www.ADVFN.com

For further information please contact: 

ADVFN PLC

Michael Hodges, Chairman
+44 (0) 207 070 0909
Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com
Roland Cornish/Michael Cornish +44 (0) 207 628 3396

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above.  

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Clem Chambers

2

Reason for notification

a)

Position / status

CEO

b)

Initial notification

/Amendment

Initial

3

Details of the issuer,  emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ADVFN plc

b)

LEI

21380042SDV1E1ZVIY40

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description  of  the financial instrument, type of instrument

Identification code

Ordinary shares of 0.2 pence each in ADVFN plc

ISIN GB00BPT24C10

Nature of the transaction

Exercise and award of options

Price(s) and volumes(s)

Options exercised:

Price(s) Volumes(s)
£0.3125 40,000

Options granted:

Exercise Price(s) Volumes(s)
£0.275 80,000

d)

Aggregated information

Options exercised:

Price(s) Volumes(s)
£0.3125 40,000

Options granted:

Exercise Price(s) Volumes(s)
£0.275 80,000

e)

Date of the transaction

15 January 2019

f)

Place of the transaction

Outside a trading venue

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHZQLFFKFFLBBK